These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8508145)
21. [Characteristics of virion formation during mixed infection with influenza viruses A and B]. Sklianskaia EI; Amvros'eva TV; Kaverin NV Mol Gen Mikrobiol Virusol; 1985 Oct; (10):46-8. PubMed ID: 3842740 [TBL] [Abstract][Full Text] [Related]
22. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin. Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946 [TBL] [Abstract][Full Text] [Related]
23. A humanized anti-M2 scFv shows protective in vitro activity against influenza. Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791 [TBL] [Abstract][Full Text] [Related]
24. Cell cooperation in antibody responses to influenza virus. I. priming of helper t cells by internal components of virion. Russell SM; Liew FY Eur J Immunol; 1980 Oct; 10(10):791-6. PubMed ID: 6968682 [TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus. Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378 [TBL] [Abstract][Full Text] [Related]
26. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Roberts PC; Lamb RA; Compans RW Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697 [TBL] [Abstract][Full Text] [Related]
27. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture. Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449 [TBL] [Abstract][Full Text] [Related]
28. H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap. Hackett CJ; Askonas BA Immunology; 1982 Mar; 45(3):431-8. PubMed ID: 6977485 [TBL] [Abstract][Full Text] [Related]
29. Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Kretzschmar E; Bui M; Rose JK Virology; 1996 Jun; 220(1):37-45. PubMed ID: 8659126 [TBL] [Abstract][Full Text] [Related]
30. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription. Mukhtar MM; Li S; Li W; Wan T; Mu Y; Wei W; Kang L; Rasool ST; Xiao Y; Zhu Y; Wu J Int J Biochem Cell Biol; 2009 Mar; 41(3):554-60. PubMed ID: 18687409 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model. Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959 [TBL] [Abstract][Full Text] [Related]
32. [Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics]. Machała MK; Brydak LB Pol Merkur Lekarski; 2006 Sep; 21(123):270-6. PubMed ID: 17163190 [TBL] [Abstract][Full Text] [Related]
33. Structured model of influenza virus replication in MDCK cells. Sidorenko Y; Reichl U Biotechnol Bioeng; 2004 Oct; 88(1):1-14. PubMed ID: 15384040 [TBL] [Abstract][Full Text] [Related]
34. Ultrastructural lectinocytochemistry of fowl plague virus-infected and uninfected MDCK cells. Cmarková J; Cmarko D; Závodská E; Ellinger A; Pavelka M; Ciampor F Acta Virol; 1995 Apr; 39(2):85-93. PubMed ID: 7676941 [TBL] [Abstract][Full Text] [Related]
35. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope. Lipatov AS; Gitelman AK; Smirnov YuA Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015 [TBL] [Abstract][Full Text] [Related]
36. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of neutralization of influenza virus infectivity by antibodies. Knossow M; Gaudier M; Douglas A; Barrère B; Bizebard T; Barbey C; Gigant B; Skehel JJ Virology; 2002 Oct; 302(2):294-8. PubMed ID: 12441073 [TBL] [Abstract][Full Text] [Related]
38. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958 [TBL] [Abstract][Full Text] [Related]
40. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor. Taylor HP; Dimmock NJ Virology; 1994 Nov; 205(1):360-3. PubMed ID: 7975232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]